APA (7th ed.) Citation

Wang, S., Wang, X., Ding, J., Zhang, X., Zhu, H., Fan, Y., & Sun, C. Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Wang, Shiyi, Xiaojian Wang, Jing Ding, Xudong Zhang, Hongmei Zhu, Yihong Fan, and Changbo Sun. Disproportionality Analysis of Upadacitinib-related Adverse Events in Inflammatory Bowel Disease Using the FDA Adverse Event Reporting System. Frontiers Media S.A.

MLA (9th ed.) Citation

Wang, Shiyi, et al. Disproportionality Analysis of Upadacitinib-related Adverse Events in Inflammatory Bowel Disease Using the FDA Adverse Event Reporting System. Frontiers Media S.A.